Dr Reddy’s Laboratories (RDY) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Dr. Reddy’s Laboratories has expanded its global footprint by establishing a new wholly-owned subsidiary, Dr. Reddy’s Denmark ApS, in Denmark. This strategic move, aligning with the company’s main pharmaceutical and biotechnological business, involves the subsidiary promoting production and related activities in Denmark. The cash-funded acquisition makes Dr. Reddy’s Denmark ApS a step-down subsidiary of the parent company.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
